000 01272 a2200337 4500
005 20250518000405.0
264 0 _c20200610
008 202006s 0 0 eng d
022 _a1477-0377
024 7 _a10.1177/1358863X18796936
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBonaca, Marc P
245 0 0 _aPolyvascular disease and risk: When two is not better than one.
_h[electronic resource]
260 _bVascular medicine (London, England)
_c12 2018
300 _a531-533 p.
_bdigital
500 _aPublication Type: Editorial; Research Support, Non-U.S. Gov't
650 0 4 _aCardiovascular Diseases
_xepidemiology
650 0 4 _aCerebrovascular Disorders
_xcomplications
650 0 4 _aCoronary Artery Disease
_xcomplications
650 0 4 _aFibrinolytic Agents
_xclassification
650 0 4 _aHumans
650 0 4 _aPatient Selection
650 0 4 _aPeripheral Arterial Disease
_xcomplications
650 0 4 _aRisk Assessment
650 0 4 _aRisk Factors
650 0 4 _aSecondary Prevention
_xmethods
650 0 4 _aSeverity of Illness Index
650 0 4 _aThrombosis
_xetiology
773 0 _tVascular medicine (London, England)
_gvol. 23
_gno. 6
_gp. 531-533
856 4 0 _uhttps://doi.org/10.1177/1358863X18796936
_zAvailable from publisher's website
999 _c28852800
_d28852800